Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167079285> ?p ?o ?g. }
- W2167079285 endingPage "4049" @default.
- W2167079285 startingPage "4039" @default.
- W2167079285 abstract "Key points We addressed the hypothesis that the heterocyclic aldehyde 5‐hydroxymethyl‐2‐furfural (5HMF) may act synergistically to ameliorate the complications of sickle cell disease through effects on red blood cell (RBC) membrane transport, in addition to its well‐known action of increasing the oxygen affinity of the abnormal form of haemoglobin, HbS. 5HMF was found to reduce deoxygenation‐induced dehydration of RBCs, whether in response to maintained deoxygenation or cyclical deoxygenation/re‐oxygenation. Acting at low millimolar concentrations, 5HMF reduced the activity of deoxygenation‐induced cation conductance (sometimes termed P sickle ), an effect which correlated with reduction in sickling. 5HMF similarly inhibited deoxygenation‐induced activation of the Ca 2+ ‐activated K + channel (or Gardos channel), an effect not seen following pharmacologically mediated increases in intracellular Ca 2+ via the ionophore A23187. Deoxygenation‐induced phosphatidylserine exposure, which is associated with Ca 2+ entry via P sickle , was also inhibited by 5HMF. By contrast, effects of 5HMF on the K + –Cl − cotransporter (KCC) were modest, with slight inhibition following treatment with N ‐ethylmaleimide (NEM) to abolish activity of its regulatory protein kinases, but stimulation in RBCs untreated with NEM. It would therefore appear that an important beneficial action of 5HMF, in addition to effects on HbS oxygen affinity, is reduction in P sickle ‐mediated Ca 2+ entry following RBC sickling, thereby inhibiting the deleterious sequelae of Gardos channel activation, RBC dehydration and also lipid scrambling. Abstract The heterocyclic aldehyde 5‐hydroxymethyl‐2‐furfural (5HMF) interacts allosterically with the abnormal form of haemoglobin (Hb), HbS, in red blood cells (RBCs) from patients with sickle cell disease (SCD), thereby increasing oxygen affinity and decreasing HbS polymerization and RBC sickling during hypoxia. We hypothesized that should 5HMF also inhibit the main cation pathways implicated in the dehydration of RBCs from SCD patients – the deoxygenation‐induced cation pathway (P sickle ), the Ca 2+ ‐activated K + channel (the Gardos channel) and the K + –Cl − cotransporter (KCC) – it would have a synergistic effect in protection against sickling, directly through interacting with HbS, and indirectly through maintaining hydration and reducing [HbS]. This study was therefore designed to investigate the effects of 5HMF on RBC volume and K + permeability in vitro . 5HMF markedly reduced the deoxygenation‐induced dehydration of RBCs whether in response to maintained deoxygenation or to cyclical deoxygenation/re‐oxygenation. 5HMF was found to inhibit P sickle , an effect which correlated with its effects on sickling. Deoxygenation‐induced activation of the Gardos channel and exposure of phosphatidylserine were also inhibited, probably indirectly via reduced entry of Ca 2+ through the P sickle pathway. Effects of 5HMF on KCC were more modest with a slight inhibition in N ‐ethylmaleimide (NEM, 1 m m )‐treated RBCs and stimulation in RBCs untreated with NEM. These findings support the hypothesis that 5HMF may also be beneficial through effects on RBC ion and water homeostasis." @default.
- W2167079285 created "2016-06-24" @default.
- W2167079285 creator A5009471528 @default.
- W2167079285 creator A5027312752 @default.
- W2167079285 creator A5044957715 @default.
- W2167079285 creator A5046987146 @default.
- W2167079285 creator A5082392112 @default.
- W2167079285 date "2014-08-13" @default.
- W2167079285 modified "2023-10-16" @default.
- W2167079285 title "Effects of 5‐hydroxymethyl‐2‐furfural on the volume and membrane permeability of red blood cells from patients with sickle cell disease" @default.
- W2167079285 cites W1499118957 @default.
- W2167079285 cites W1499254173 @default.
- W2167079285 cites W1536409680 @default.
- W2167079285 cites W1561566187 @default.
- W2167079285 cites W1591353450 @default.
- W2167079285 cites W1596260168 @default.
- W2167079285 cites W166250711 @default.
- W2167079285 cites W170695777 @default.
- W2167079285 cites W1969270968 @default.
- W2167079285 cites W1973465668 @default.
- W2167079285 cites W1978915621 @default.
- W2167079285 cites W1980754701 @default.
- W2167079285 cites W1998802474 @default.
- W2167079285 cites W2003752024 @default.
- W2167079285 cites W2007001262 @default.
- W2167079285 cites W2008170620 @default.
- W2167079285 cites W2015929262 @default.
- W2167079285 cites W2016914762 @default.
- W2167079285 cites W2019202680 @default.
- W2167079285 cites W2020615081 @default.
- W2167079285 cites W2053495832 @default.
- W2167079285 cites W2054887228 @default.
- W2167079285 cites W2059716230 @default.
- W2167079285 cites W2062856652 @default.
- W2167079285 cites W2066473104 @default.
- W2167079285 cites W2070088403 @default.
- W2167079285 cites W2075460586 @default.
- W2167079285 cites W2083891352 @default.
- W2167079285 cites W2086219740 @default.
- W2167079285 cites W2087983953 @default.
- W2167079285 cites W2091627209 @default.
- W2167079285 cites W2091647374 @default.
- W2167079285 cites W2102819228 @default.
- W2167079285 cites W2103049273 @default.
- W2167079285 cites W2145731224 @default.
- W2167079285 cites W2146325907 @default.
- W2167079285 cites W2147792416 @default.
- W2167079285 cites W2174561121 @default.
- W2167079285 cites W2284789459 @default.
- W2167079285 cites W2285115828 @default.
- W2167079285 cites W2322453619 @default.
- W2167079285 cites W2335076886 @default.
- W2167079285 cites W2403480980 @default.
- W2167079285 cites W2436903794 @default.
- W2167079285 cites W2588677591 @default.
- W2167079285 cites W3093093377 @default.
- W2167079285 cites W4211186710 @default.
- W2167079285 cites W4254888181 @default.
- W2167079285 cites W575318027 @default.
- W2167079285 doi "https://doi.org/10.1113/jphysiol.2014.277681" @default.
- W2167079285 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4198013" @default.
- W2167079285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25015917" @default.
- W2167079285 hasPublicationYear "2014" @default.
- W2167079285 type Work @default.
- W2167079285 sameAs 2167079285 @default.
- W2167079285 citedByCount "22" @default.
- W2167079285 countsByYear W21670792852014 @default.
- W2167079285 countsByYear W21670792852015 @default.
- W2167079285 countsByYear W21670792852016 @default.
- W2167079285 countsByYear W21670792852017 @default.
- W2167079285 countsByYear W21670792852018 @default.
- W2167079285 countsByYear W21670792852019 @default.
- W2167079285 countsByYear W21670792852020 @default.
- W2167079285 countsByYear W21670792852021 @default.
- W2167079285 countsByYear W21670792852022 @default.
- W2167079285 countsByYear W21670792852023 @default.
- W2167079285 crossrefType "journal-article" @default.
- W2167079285 hasAuthorship W2167079285A5009471528 @default.
- W2167079285 hasAuthorship W2167079285A5027312752 @default.
- W2167079285 hasAuthorship W2167079285A5044957715 @default.
- W2167079285 hasAuthorship W2167079285A5046987146 @default.
- W2167079285 hasAuthorship W2167079285A5082392112 @default.
- W2167079285 hasBestOaLocation W21670792851 @default.
- W2167079285 hasConcept C12554922 @default.
- W2167079285 hasConcept C161790260 @default.
- W2167079285 hasConcept C185592680 @default.
- W2167079285 hasConcept C2776557347 @default.
- W2167079285 hasConcept C2779778602 @default.
- W2167079285 hasConcept C55493867 @default.
- W2167079285 hasConcept C86803240 @default.
- W2167079285 hasConceptScore W2167079285C12554922 @default.
- W2167079285 hasConceptScore W2167079285C161790260 @default.
- W2167079285 hasConceptScore W2167079285C185592680 @default.
- W2167079285 hasConceptScore W2167079285C2776557347 @default.
- W2167079285 hasConceptScore W2167079285C2779778602 @default.
- W2167079285 hasConceptScore W2167079285C55493867 @default.
- W2167079285 hasConceptScore W2167079285C86803240 @default.
- W2167079285 hasIssue "18" @default.